SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-322764
Filing Date
2018-11-09
Accepted
2018-11-08 18:03:05
Documents
2
Period of Report
2018-11-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d635338d8k.htm 8-K 15895
2 EX-5.1 d635338dex51.htm EX-5.1 14596
  Complete submission text file 0001193125-18-322764.txt   31551
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 181170894
SIC: 2836 Biological Products, (No Diagnostic Substances)